<DOC>
	<DOCNO>NCT00765453</DOCNO>
	<brief_summary>Study hypothesis : The purpose study determine whether Intracoronary infusion autologous bone marrow derive progenitor cell patient undergo primary angioplasty acute anterior myocardial infarction lead improvement cardiac function great see placebo alone . Aims - To demonstrate safe feasible deliver autologous bone marrow derive stem cell within hour primary angioplasty procedure - To demonstrate effect autologous bone marrow derive stem cell cardiac function use cardiac MRI ( cardiac CT ) , echocardiography leave ventriculography . - To demonstrate effect autologous bone marrow derive stem cell addition standard care lead improvement cardiac function compare patient saline ( placebo ) standard care .</brief_summary>
	<brief_title>Bone Marrow Derived Adult Stem Cells Acute Anterior Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Anterior Wall Myocardial Infarction</mesh_term>
	<criteria>Patients present Heart Attack Centre acute anterior myocardial infarction ( ST elevation least 2 contiguous anterior lead ≥ 0.2 mV ) treat acute PCI stent implantation within 24 hour symptom onset Acute PCI / stent implantation successful ( residual stenosis visually &lt; 30 % TIMI flow ≥ 2 ) . At time inclusion patient long require i.v . catecholamine mechanical hemodynamic support ( aortic balloon pump ) Significant regional wall motion abnormality LV angiogram time acute PCI LAD territory Age 18 80 Years ( primary angioplasty confers adverse prognosis age 80 year ) Written informed consent recruiting centre native language Regional wall motion abnormality outside area involve index acute myocardial infarction Need revascularise additional vessel , outside infarct artery plan procedure ( vessel treat baseline ) Arteriovenous malformation aneurysms Active infection , fever diarrhoea within last 4 week Chronic inflammatory disease Known HIV infection active hepatitis Neoplastic disease without documented remission within past 5 year Cerebrovascular insult within 3 month Impaired renal function ( creatinine &gt; 200mmol ) time cell therapy Significant liver disease ( GOT &gt; 2x upper limit ) spontaneous INR &gt; 1,5 ) Anemia ( hemoglobin &lt; 8.5 mg/dl ) Platelet count &lt; 100.000/µl Hypersplenism Known allergy intolerance clopidogrel , heparin abciximab History bleed disorder Gastrointestinal bleeding within 3 month Major surgical procedure trauma within 2 month Uncontrolled hypertension Pregnancy Mental retardation lead inability obtain informed consent Previously perform stem / progenitor cell therapy Participation another clinical trial within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Heart attack</keyword>
	<keyword>Anterior Myocardial infarction ( MI )</keyword>
	<keyword>adult stem cell</keyword>
	<keyword>bone marrow progenitor cell</keyword>
	<keyword>bone marrow stem cell</keyword>
	<keyword>autologous</keyword>
	<keyword>leave ventricular function</keyword>
	<keyword>intracoronary injection</keyword>
</DOC>